$61 -1.8 -2.9%
Last Trade - 20/04/21
| Market Cap | £999.5m |
| Enterprise Value | £834.2m |
| Revenue | £220.6m |
| Position in Universe | 2530th / 6849 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 159 | 202.8 | 249.4 | 358.1 | 361.9 | 308.5 | 330.9 | 362.8 | +14.2% | ||
| +91.4 | +73.9 | +34.2 | +76.4 | -57.7 | ||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | November 27, 2001 |
| Public Since | February 14, 2014 |
| No. of Shareholders: | 27 |
| No. of Employees: | 938 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 , |
| Exchange | NASDAQ Global Select Market |
| Shares in Issue | 22,248,694 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 326 Bollay Dr, GOLETA, 93117-5550, United States |
| Web | https://www.inogen.com/ |
| Phone | +1 805 5620500 |
| Contact | Matthew Pigeon (IR Contact Officer) |
| Auditors | Deloitte & Touche LLP |
As of 20/04/21, shares in Inogen Inc are trading at $61, giving the company a market capitalisation of £999.5m. This share price information is delayed by 15 minutes.
Shares in Inogen Inc are currently trading at $61 and the price has moved by 27.42% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Inogen Inc price has moved by -14.05% over the past year.
Of the analysts with advisory recommendations for Inogen Inc, there are there are currently 0 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Inogen Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Inogen Inc is scheduled to issue upcoming financial results on the following dates:
Inogen Inc does not currently pay a dividend.
Inogen Inc does not currently pay a dividend.
Inogen Inc does not currently pay a dividend.
To buy shares in Inogen Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Inogen Inc are currently trading at $61, giving the company a market capitalisation of £999.5m.
Here are the trading details for Inogen Inc:
Based on an overall assessment of its quality, value and momentum, Inogen Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Inogen Inc are currently priced at $61. At that level they are trading at 6.61% premium to the analyst consensus target price of 0.00.
Analysts covering Inogen Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.708 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Inogen Inc. Over the past six months, the relative strength of its shares against the market has been 86.92%. At the current price of $61, shares in Inogen Inc are trading at 58.7% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Inogen Inc.
Inogen Inc's management team is headed by:
Here are the top five shareholders of Inogen Inc based on the size of their shareholding:
